Dr. Saima N. Kayani
Overview
Saima Kayani is a Neurologist and a Pediatrics provider in Dallas, Texas. Dr. Kayani is rated as an Advanced provider by MediFind in the treatment of Metachromatic Leukodystrophy. Her top areas of expertise are Leigh Syndrome, CLN5 Disease, CLN4 Disease, and CLN1 Disease.
Her clinical research consists of co-authoring 20 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
5323 Harry Hines Blvd., Dallas, TX 75390
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Texas Neurology, P.A.
Dr. Schiffmann is a renowned expert on neurometabolic diseases. He earned his medical degree from the University of Liège, Belgium and a Master of Health Sciences in Clinical Research from Duke University. He is board-certified in Neurology with a Special Qualification in Child Neurology and is a Fellow of the American Academy of Neurology. Dr. Schiffmann was a lead researcher at the United States National Institutes of Health in Bethesda, Maryland for over 17 years (1991-2007) and then the Director of the Institute of Metabolic Disease at the Baylor Scott & White Research Institute in Dallas, Texas, 2008-2019. Dr. Schiffmann is a Professor in the Department of Internal Medicine, Texas Christian University and a Clinical Professor, Texas A&M University Medical School College of Medicine. He is also a Senior Vice President for Clinical Research at 4D Molecular Therapeutics. Dr. Schiffmann has been performing pre-clinical and clinical research on lysosomal storage diseases since 1991 with a special focus on the natural history, pathogenesis and therapy of Fabry disease, Gaucher disease and the leukodystrophies. One of his particular interests and areas of expertise is to address patients with undiagnosed neurological diseases. Dr. Schiffmann has published 276 peer-reviewed research articles and over 15 book chapters. Dr. Schiffmann is rated as an Elite provider by MediFind in the treatment of Metachromatic Leukodystrophy. His top areas of expertise are Gaucher Disease Type 3, Fabry Disease, Gaucher Disease, and Leukodystrophy.
UT Southwestern Medical Center
Brendan Kelley is a Neurologist in Dallas, Texas. Dr. Kelley is rated as a Distinguished provider by MediFind in the treatment of Metachromatic Leukodystrophy. His top areas of expertise are Lewy Body Dementia (LBD), Cerebellar Degeneration, Neuronal Intranuclear Inclusion Disease (NIID), and Alzheimer's Disease.
UT Southwestern - Neurology
Jennifer Thomas is a Neurologist in Dallas, Texas. Dr. Thomas has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Metachromatic Leukodystrophy. Her top areas of expertise are Aphantasia, GAPO Syndrome, Lissencephaly 1, and Hydranencephaly.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Batten DiseaseDr. Kayani isDistinguished. Learn about Batten Disease.
- CLN1 DiseaseDr. Kayani isDistinguished. Learn about CLN1 Disease.
- CLN2 DiseaseDr. Kayani isDistinguished. Learn about CLN2 Disease.
- CLN3 DiseaseDr. Kayani isDistinguished. Learn about CLN3 Disease.
- CLN4 DiseaseDr. Kayani isDistinguished. Learn about CLN4 Disease.
- CLN5 DiseaseDr. Kayani isDistinguished. Learn about CLN5 Disease.
- Advanced
- Adrenoleukodystrophy (ALD)Dr. Kayani isAdvanced. Learn about Adrenoleukodystrophy (ALD).
- Agyria Pachygyria PolymicrogyriaDr. Kayani isAdvanced. Learn about Agyria Pachygyria Polymicrogyria.
- Alpha MannosidosisDr. Kayani isAdvanced. Learn about Alpha Mannosidosis.
- AphantasiaDr. Kayani isAdvanced. Learn about Aphantasia.
- AspartylglucosaminuriaDr. Kayani isAdvanced. Learn about Aspartylglucosaminuria.
- Beta-MannosidosisDr. Kayani isAdvanced. Learn about Beta-Mannosidosis.
- Experienced
- 15q11.2 MicrodeletionDr. Kayani isExperienced. Learn about 15q11.2 Microdeletion.
- Absence SeizureDr. Kayani isExperienced. Learn about Absence Seizure.
- Adrenal Insufficiency PediatricDr. Kayani isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Aicardi SyndromeDr. Kayani isExperienced. Learn about Aicardi Syndrome.
- Autism Spectrum DisorderDr. Kayani isExperienced. Learn about Autism Spectrum Disorder.
- Autosomal Recessive Congenital Methemoglobinemia